Chronic pain, which lasts for three months or longer, is difficult to treat. Many people rely on opioid pain medications, but ...

NIH-Funded Research Team Engineers New Drug Targeting Pain Sensation Pathway with Implications for Chronic Pain Treatment ...

In “Hazard,” New Orleans actor Dave Davis plays John Lang, a cop in a small town in Appalachia. He’s talking with his ...

Catarina Craveiro, a biomedical research technician from Lisbon, had been hobbled by lower back pain from scoliosis since ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

President Trump suspended tariffs intended to stop fentanyl from entering the United States. Here’s what to know about the ...

The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.

A James Island pharmacist is looking to the future of pain management thanks to the Food and Drug Administration approving a new treatment.

A multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to optimize pain management and reduce the need for opioids after mastectomy ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Researchers create a cannabis-derived compound that relieves pain without the risk of addiction or mind-altering effects.